Literature DB >> 1846900

Ig repertoire of human polyspecific antibodies and B cell ontogeny.

V Guigou1, B Guilbert, D Moinier, C Tonnelle, L Boubli, S Avrameas, M Fougereau, F Fumoux.   

Abstract

A total of 463 EBV Ig-secreting clones were derived from embryonic tissues, cord blood, and adult peripheral blood. Subcloning and analysis of the H and K loci (germline vs rearranged DNA status) of 44 primary clones insured clonality in at least 92% of cases. Whatever the cell origin, a somewhat constant proportion of clones (i.e., 11 to 16%) expressed polyspecific antibodies when tested on a panel of nine Ag, including self-Ag. The VH and VK repertoires have been studied using VH1-VH6 and VK1-VK4 family-specific probes. For all EBV clones the VH and VK utilization was similar to that of the normal untransformed population. A correlation was observed between the level of expression and the gene number for VH, whereas a clear distortion appeared for VK. Moreover, the usage pattern of VH and VK families of the polyspecific clones did not significantly differ from that of clones of unknown specificity, suggesting that polyspecificity was not linked to a restricted repertoire.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1846900

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Germline variable region gene segment derivation of human monoclonal anti-Rh(D) antibodies. Evidence for affinity maturation by somatic hypermutation and repertoire shift.

Authors:  J M Bye; C Carter; Y Cui; B D Gorick; S Songsivilai; G Winter; N C Hughes-Jones; J D Marks
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

2.  Protein dynamics and the immunological evolution of molecular recognition.

Authors:  Ralph Jimenez; Georgina Salazar; Jun Yin; Taiha Joo; Floyd E Romesberg
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-04       Impact factor: 11.205

3.  Antibody evolution constrains conformational heterogeneity by tailoring protein dynamics.

Authors:  Jörg Zimmermann; Erin L Oakman; Ian F Thorpe; Xinghua Shi; Paul Abbyad; Charles L Brooks; Steven G Boxer; Floyd E Romesberg
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-05       Impact factor: 11.205

4.  VHDJH gene sequences and antigen reactivity of monoclonal antibodies produced by human B-1 cells: evidence for somatic selection.

Authors:  E W Schettino; S K Chai; M T Kasaian; H W Schroeder; P Casali
Journal:  J Immunol       Date:  1997-03-01       Impact factor: 5.422

5.  Invariance and restriction toward a limited set of self-antigens characterize neonatal IgM antibody repertoires and prevail in autoreactive repertoires of healthy adults.

Authors:  L Mouthon; A Nobrega; N Nicolas; S V Kaveri; C Barreau; A Coutinho; M D Kazatchkine
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

6.  Immunoglobulin heavy chain gene expression in peripheral blood B lymphocytes.

Authors:  C Huang; A K Stewart; R S Schwartz; B D Stollar
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

7.  Monospecific but not polyreactive human hybridoma rheumatoid factors exhibit preferential binding specificities for IgG3 and IgG4.

Authors:  M M Newkirk; J Rauch
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

8.  Immunoglobulin heavy chain variable region gene utilization by B cell hybridomas derived from rheumatoid synovial tissue.

Authors:  C M Brown; C Longhurst; G Haynes; C Plater-Zyberk; A Malcolm; R N Maini
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

9.  Human immunoglobulin heavy-chain minilocus recombination in transgenic mice: gene-segment use in mu and gamma transcripts.

Authors:  N Tuaillon; L D Taylor; N Lonberg; P W Tucker; J D Capra
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

10.  Common idiotypes expressed on human, monoclonal, abnormal immunoglobulins and cryoglobulins with polyreactive autoantibody activities.

Authors:  M R Barbouche; B Guilbert; S Makni; Y Gorgi; K Ayed; S Avrameas
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.